DTwP-HepB-IPV-Hib (LG Life Science)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameDTwP-HepB-IPV-Hib (LG Life Science)
Drug Alias NameDTwP-HepB-Sabin IPV-Hib全液体Hib-DTP-肝炎-B-Sabin IPV疫苗-LG化学LBVD
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BPoliomyelitisTetanus +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPhilippines
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis BPoliomyelitisTetanus +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A